Design, Synthesis, and Evaluation of Tetrasubstituted Pyridines as Potent 5-HT2C Receptor Agonists.

ACS Med Chem Lett

Worldwide Medicinal Chemistry, and Discovery Biology, Pfizer Global Research and Development, Sandwich Laboratories , Sandwich, Kent CT13 9NJ, U.K.

Published: March 2015

A series of pyrido[3,4-d]azepines that are potent and selective 5-HT2C receptor agonists is disclosed. Compound 7 (PF-04781340) is identified as a suitable lead owing to good 5-HT2C potency, selectivity over 5-HT2B agonism, and in vitro ADME properties commensurate with an orally available and CNS penetrant profile. The synthesis of a novel bicyclic tetrasubstituted pyridine core template is outlined, including rationale to account for the unexpected formation of aminopyridine 13 resulting from an ammonia cascade cyclization.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360148PMC
http://dx.doi.org/10.1021/ml500507vDOI Listing

Publication Analysis

Top Keywords

5-ht2c receptor
8
receptor agonists
8
design synthesis
4
synthesis evaluation
4
evaluation tetrasubstituted
4
tetrasubstituted pyridines
4
pyridines potent
4
potent 5-ht2c
4
agonists series
4
series pyrido[34-d]azepines
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!